Mohamed Béjaoui

A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia

Maria Domenica Cappellini, Vip Viprakasit, Alì Taher et al. · New England Journal of Medicine · 2020 · 306 citations

Medicine, Hematology, Molecular Medicine +13

X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production

Orchidée Filipe‐Santos, Jacinta Bustamante, Margje H. Haverkamp et al. · The Journal of Experimental Medicine · 2006 · 279 citations · Full text

Life Sciences, Genetics, Immunology +17

Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up

Maria Domenica Cappellini, Mohamed Béjaoui, Leyla Ağaoğlu et al. · Blood · 2011 · 220 citations · Full text

Medicine, Hematology, Pharmacology +14

The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency

Karin R. Engelhardt, Michael E. Gertz, Sevgi Keleş et al. · Journal of Allergy and Clinical Immunology · 2015 · 193 citations · Full text

Life Sciences, Immunology, Clinical Immunology +12

Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels

Atfa Sassi, Sandra Lazaroski, Gang Wu et al. · Journal of Allergy and Clinical Immunology · 2014 · 192 citations · Full text

Life Sciences, Genetics, Immunology +16